The phase 3, multi-center, open-label, randomized CONTACT-02 trial, directed by Neeraj Agarwal of the Huntsman Cancer Institute at the University…
featured news home
Themed Strengthening our combined commitment to conquer cancer, VHIO’s Scientific Report 2024 highlights some of the many research contributions and…
The ESMO GI 2025 Congress brought together specialists from around the world in Barcelona from July 2 to 5 to…
On July 1st, the Vall d’Hebron Institute of Oncology (VHIO) hosted the 1st Annual Meeting of the SAGITTARIUS Project, an initiative…
Following the success of its inaugural edition, the Vall d’Hebron Institute of Oncology (VHIO), in partnership with the BBVA Foundation,…
The phase 3 clinical trial KEYNOTE-689 shows that incorporating the monoclonal antibody pembrolizumab before and after surgery, alongside standard of…
On May 1st, Unió Esportiva Avià organized a women’s football tournament to support breast cancer research at VHIO. In this…
On 10 June, the organizers of the Padel Movember tournament visited the VHIO facilities to present the cheque for €5.601…
As the academic year comes to an end, so does our most established science outreach initiative: the Escola i Ciència…
